Viewing Study NCT00060294


Ignite Creation Date: 2025-12-25 @ 1:35 AM
Ignite Modification Date: 2026-02-09 @ 7:18 AM
Study NCT ID: NCT00060294
Status: TERMINATED
Last Update Posted: 2013-01-08
First Post: 2003-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Waldenström macroglobulinemia View